Status:
UNKNOWN
Normoalbuminuric Chronic Kidney Disease in Type 2 Diabetes
Lead Sponsor:
Assiut University
Conditions:
Chronic Kidney Diseases
Eligibility:
All Genders
18-65 years
Brief Summary
* Assess the prevalence of normoalbuminuric CKD in Type 2 diabetes. * Study the risk factors of normoalbuminuric CKD in patients with type 2 diabetes.
Detailed Description
Diabetes mellitus (DM) is considered a major cause of chronic kidney disease (CKD), where about 40% of the diabetics develop diabetic kidney disease (DKD) resulting in albuminuria, reduction of glomer...
Eligibility Criteria
Inclusion
- Patients age \>18 -65 years .
- Diagnosed previously with T2DM.
Exclusion
- Patients with type 1 diabetes,
- Patients with secondary diabetes,
- Patients with gestational diabetes
- Patients with severe acute or chronic hepatic or cardiac diseases.
- Patients with Past or present history of malignancy .
- Patients with in need for renal replacement therapy.
- Patients with other probable causes for CKD.
- Patients with an active urinary sediment and nephrotic - range proteinuria .
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04411342
Start Date
December 1 2020
End Date
July 1 2021
Last Update
June 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.